Global Vaccines For Children (VFC) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vaccines For Children (VFC) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Vaccines For Children (VFC) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Vaccines For Children (VFC) by Country/Region, 2017, 2022 & 2028

2.2 Vaccines For Children (VFC) Segment by Type

2.2.1 Recombinant Vaccines

2.2.2 Viral Vaccines

2.2.3 Polysaccharide Vaccines

2.2.4 Others

2.3 Vaccines For Children (VFC) Sales by Type

2.3.1 Global Vaccines For Children (VFC) Sales Market Share by Type (2017-2022)

2.3.2 Global Vaccines For Children (VFC) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Vaccines For Children (VFC) Sale Price by Type (2017-2022)

2.4 Vaccines For Children (VFC) Segment by Application

2.4.1 Government Institution

2.4.2 Private Sector

2.4.3 Other

2.5 Vaccines For Children (VFC) Sales by Application

2.5.1 Global Vaccines For Children (VFC) Sale Market Share by Application (2017-2022)

2.5.2 Global Vaccines For Children (VFC) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Vaccines For Children (VFC) Sale Price by Application (2017-2022)

3 Global Vaccines For Children (VFC) by Company

3.1 Global Vaccines For Children (VFC) Breakdown Data by Company

3.1.1 Global Vaccines For Children (VFC) Annual Sales by Company (2020-2022)

3.1.2 Global Vaccines For Children (VFC) Sales Market Share by Company (2020-2022)

3.2 Global Vaccines For Children (VFC) Annual Revenue by Company (2020-2022)

3.2.1 Global Vaccines For Children (VFC) Revenue by Company (2020-2022)

3.2.2 Global Vaccines For Children (VFC) Revenue Market Share by Company (2020-2022)

3.3 Global Vaccines For Children (VFC) Sale Price by Company

3.4 Key Manufacturers Vaccines For Children (VFC) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vaccines For Children (VFC) Product Location Distribution

3.4.2 Players Vaccines For Children (VFC) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Vaccines For Children (VFC) by Geographic Region

4.1 World Historic Vaccines For Children (VFC) Market Size by Geographic Region (2017-2022)

4.1.1 Global Vaccines For Children (VFC) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Vaccines For Children (VFC) Annual Revenue by Geographic Region

4.2 World Historic Vaccines For Children (VFC) Market Size by Country/Region (2017-2022)

4.2.1 Global Vaccines For Children (VFC) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Vaccines For Children (VFC) Annual Revenue by Country/Region

4.3 Americas Vaccines For Children (VFC) Sales Growth

4.4 APAC Vaccines For Children (VFC) Sales Growth

4.5 Europe Vaccines For Children (VFC) Sales Growth

4.6 Middle East & Africa Vaccines For Children (VFC) Sales Growth

5 Americas

5.1 Americas Vaccines For Children (VFC) Sales by Country

5.1.1 Americas Vaccines For Children (VFC) Sales by Country (2017-2022)

5.1.2 Americas Vaccines For Children (VFC) Revenue by Country (2017-2022)

5.2 Americas Vaccines For Children (VFC) Sales by Type

5.3 Americas Vaccines For Children (VFC) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vaccines For Children (VFC) Sales by Region

6.1.1 APAC Vaccines For Children (VFC) Sales by Region (2017-2022)

6.1.2 APAC Vaccines For Children (VFC) Revenue by Region (2017-2022)

6.2 APAC Vaccines For Children (VFC) Sales by Type

6.3 APAC Vaccines For Children (VFC) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Vaccines For Children (VFC) by Country

7.1.1 Europe Vaccines For Children (VFC) Sales by Country (2017-2022)

7.1.2 Europe Vaccines For Children (VFC) Revenue by Country (2017-2022)

7.2 Europe Vaccines For Children (VFC) Sales by Type

7.3 Europe Vaccines For Children (VFC) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vaccines For Children (VFC) by Country

8.1.1 Middle East & Africa Vaccines For Children (VFC) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Vaccines For Children (VFC) Revenue by Country (2017-2022)

8.2 Middle East & Africa Vaccines For Children (VFC) Sales by Type

8.3 Middle East & Africa Vaccines For Children (VFC) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Vaccines For Children (VFC)

10.3 Manufacturing Process Analysis of Vaccines For Children (VFC)

10.4 Industry Chain Structure of Vaccines For Children (VFC)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Vaccines For Children (VFC) Distributors

11.3 Vaccines For Children (VFC) Customer

12 World Forecast Review for Vaccines For Children (VFC) by Geographic Region

12.1 Global Vaccines For Children (VFC) Market Size Forecast by Region

12.1.1 Global Vaccines For Children (VFC) Forecast by Region (2023-2028)

12.1.2 Global Vaccines For Children (VFC) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Vaccines For Children (VFC) Forecast by Type

12.7 Global Vaccines For Children (VFC) Forecast by Application

13 Key Players Analysis

13.1 GSK

13.1.1 GSK Company Information

13.1.2 GSK Vaccines For Children (VFC) Product Offered

13.1.3 GSK Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GSK Main Business Overview

13.1.5 GSK Latest Developments

13.2 Sanofi

13.2.1 Sanofi Company Information

13.2.2 Sanofi Vaccines For Children (VFC) Product Offered

13.2.3 Sanofi Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Main Business Overview

13.2.5 Sanofi Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Vaccines For Children (VFC) Product Offered

13.3.3 Merck Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 Pfizer

13.4.1 Pfizer Company Information

13.4.2 Pfizer Vaccines For Children (VFC) Product Offered

13.4.3 Pfizer Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer Main Business Overview

13.4.5 Pfizer Latest Developments

13.5 Jintan

13.5.1 Jintan Company Information

13.5.2 Jintan Vaccines For Children (VFC) Product Offered

13.5.3 Jintan Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Jintan Main Business Overview

13.5.5 Jintan Latest Developments

13.6 CSL

13.6.1 CSL Company Information

13.6.2 CSL Vaccines For Children (VFC) Product Offered

13.6.3 CSL Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 CSL Main Business Overview

13.6.5 CSL Latest Developments

13.7 MedImmune LLC

13.7.1 MedImmune LLC Company Information

13.7.2 MedImmune LLC Vaccines For Children (VFC) Product Offered

13.7.3 MedImmune LLC Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 MedImmune LLC Main Business Overview

13.7.5 MedImmune LLC Latest Developments

13.8 J&J(Crucell)

13.8.1 J&J(Crucell) Company Information

13.8.2 J&J(Crucell) Vaccines For Children (VFC) Product Offered

13.8.3 J&J(Crucell) Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 J&J(Crucell) Main Business Overview

13.8.5 J&J(Crucell) Latest Developments

13.9 China National Biotec

13.9.1 China National Biotec Company Information

13.9.2 China National Biotec Vaccines For Children (VFC) Product Offered

13.9.3 China National Biotec Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 China National Biotec Main Business Overview

13.9.5 China National Biotec Latest Developments

13.10 Tiantan

13.10.1 Tiantan Company Information

13.10.2 Tiantan Vaccines For Children (VFC) Product Offered

13.10.3 Tiantan Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Tiantan Main Business Overview

13.10.5 Tiantan Latest Developments

13.11 Hualan

13.11.1 Hualan Company Information

13.11.2 Hualan Vaccines For Children (VFC) Product Offered

13.11.3 Hualan Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Hualan Main Business Overview

13.11.5 Hualan Latest Developments

13.12 Kangtai

13.12.1 Kangtai Company Information

13.12.2 Kangtai Vaccines For Children (VFC) Product Offered

13.12.3 Kangtai Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Kangtai Main Business Overview

13.12.5 Kangtai Latest Developments

13.13 Hissen

13.13.1 Hissen Company Information

13.13.2 Hissen Vaccines For Children (VFC) Product Offered

13.13.3 Hissen Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Hissen Main Business Overview

13.13.5 Hissen Latest Developments

14 Research Findings and Conclusion

Table 1. Vaccines For Children (VFC) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Vaccines For Children (VFC) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Recombinant Vaccines

Table 4. Major Players of Viral Vaccines

Table 5. Major Players of Polysaccharide Vaccines

Table 6. Major Players of Others

Table 7. Global Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)

Table 8. Global Vaccines For Children (VFC) Sales Market Share by Type (2017-2022)

Table 9. Global Vaccines For Children (VFC) Revenue by Type (2017-2022) & ($ million)

Table 10. Global Vaccines For Children (VFC) Revenue Market Share by Type (2017-2022)

Table 11. Global Vaccines For Children (VFC) Sale Price by Type (2017-2022) & (US$/Dose)

Table 12. Global Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)

Table 13. Global Vaccines For Children (VFC) Sales Market Share by Application (2017-2022)

Table 14. Global Vaccines For Children (VFC) Revenue by Application (2017-2022)

Table 15. Global Vaccines For Children (VFC) Revenue Market Share by Application (2017-2022)

Table 16. Global Vaccines For Children (VFC) Sale Price by Application (2017-2022) & (US$/Dose)

Table 17. Global Vaccines For Children (VFC) Sales by Company (2020-2022) & (K Doses)

Table 18. Global Vaccines For Children (VFC) Sales Market Share by Company (2020-2022)

Table 19. Global Vaccines For Children (VFC) Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Vaccines For Children (VFC) Revenue Market Share by Company (2020-2022)

Table 21. Global Vaccines For Children (VFC) Sale Price by Company (2020-2022) & (US$/Dose)

Table 22. Key Manufacturers Vaccines For Children (VFC) Producing Area Distribution and Sales Area

Table 23. Players Vaccines For Children (VFC) Products Offered

Table 24. Vaccines For Children (VFC) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Vaccines For Children (VFC) Sales by Geographic Region (2017-2022) & (K Doses)

Table 28. Global Vaccines For Children (VFC) Sales Market Share Geographic Region (2017-2022)

Table 29. Global Vaccines For Children (VFC) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Vaccines For Children (VFC) Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Vaccines For Children (VFC) Sales by Country/Region (2017-2022) & (K Doses)

Table 32. Global Vaccines For Children (VFC) Sales Market Share by Country/Region (2017-2022)

Table 33. Global Vaccines For Children (VFC) Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Vaccines For Children (VFC) Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Vaccines For Children (VFC) Sales by Country (2017-2022) & (K Doses)

Table 36. Americas Vaccines For Children (VFC) Sales Market Share by Country (2017-2022)

Table 37. Americas Vaccines For Children (VFC) Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Vaccines For Children (VFC) Revenue Market Share by Country (2017-2022)

Table 39. Americas Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)

Table 40. Americas Vaccines For Children (VFC) Sales Market Share by Type (2017-2022)

Table 41. Americas Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)

Table 42. Americas Vaccines For Children (VFC) Sales Market Share by Application (2017-2022)

Table 43. APAC Vaccines For Children (VFC) Sales by Region (2017-2022) & (K Doses)

Table 44. APAC Vaccines For Children (VFC) Sales Market Share by Region (2017-2022)

Table 45. APAC Vaccines For Children (VFC) Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Vaccines For Children (VFC) Revenue Market Share by Region (2017-2022)

Table 47. APAC Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)

Table 48. APAC Vaccines For Children (VFC) Sales Market Share by Type (2017-2022)

Table 49. APAC Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)

Table 50. APAC Vaccines For Children (VFC) Sales Market Share by Application (2017-2022)

Table 51. Europe Vaccines For Children (VFC) Sales by Country (2017-2022) & (K Doses)

Table 52. Europe Vaccines For Children (VFC) Sales Market Share by Country (2017-2022)

Table 53. Europe Vaccines For Children (VFC) Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Vaccines For Children (VFC) Revenue Market Share by Country (2017-2022)

Table 55. Europe Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)

Table 56. Europe Vaccines For Children (VFC) Sales Market Share by Type (2017-2022)

Table 57. Europe Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)

Table 58. Europe Vaccines For Children (VFC) Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Vaccines For Children (VFC) Sales by Country (2017-2022) & (K Doses)

Table 60. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Vaccines For Children (VFC) Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Vaccines For Children (VFC) Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)

Table 64. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)

Table 66. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Vaccines For Children (VFC)

Table 68. Key Market Challenges & Risks of Vaccines For Children (VFC)

Table 69. Key Industry Trends of Vaccines For Children (VFC)

Table 70. Vaccines For Children (VFC) Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Vaccines For Children (VFC) Distributors List

Table 73. Vaccines For Children (VFC) Customer List

Table 74. Global Vaccines For Children (VFC) Sales Forecast by Region (2023-2028) & (K Doses)

Table 75. Global Vaccines For Children (VFC) Sales Market Forecast by Region

Table 76. Global Vaccines For Children (VFC) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Vaccines For Children (VFC) Sales Forecast by Country (2023-2028) & (K Doses)

Table 79. Americas Vaccines For Children (VFC) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Vaccines For Children (VFC) Sales Forecast by Region (2023-2028) & (K Doses)

Table 81. APAC Vaccines For Children (VFC) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Vaccines For Children (VFC) Sales Forecast by Country (2023-2028) & (K Doses)

Table 83. Europe Vaccines For Children (VFC) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Vaccines For Children (VFC) Sales Forecast by Country (2023-2028) & (K Doses)

Table 85. Middle East & Africa Vaccines For Children (VFC) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Vaccines For Children (VFC) Sales Forecast by Type (2023-2028) & (K Doses)

Table 87. Global Vaccines For Children (VFC) Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Vaccines For Children (VFC) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Vaccines For Children (VFC) Sales Forecast by Application (2023-2028) & (K Doses)

Table 91. Global Vaccines For Children (VFC) Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Vaccines For Children (VFC) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Application (2023-2028)

Table 94. GSK Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 95. GSK Vaccines For Children (VFC) Product Offered

Table 96. GSK Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 97. GSK Main Business

Table 98. GSK Latest Developments

Table 99. Sanofi Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 100. Sanofi Vaccines For Children (VFC) Product Offered

Table 101. Sanofi Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 102. Sanofi Main Business

Table 103. Sanofi Latest Developments

Table 104. Merck Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 105. Merck Vaccines For Children (VFC) Product Offered

Table 106. Merck Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 107. Merck Main Business

Table 108. Merck Latest Developments

Table 109. Pfizer Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 110. Pfizer Vaccines For Children (VFC) Product Offered

Table 111. Pfizer Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 112. Pfizer Main Business

Table 113. Pfizer Latest Developments

Table 114. Jintan Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 115. Jintan Vaccines For Children (VFC) Product Offered

Table 116. Jintan Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 117. Jintan Main Business

Table 118. Jintan Latest Developments

Table 119. CSL Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 120. CSL Vaccines For Children (VFC) Product Offered

Table 121. CSL Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 122. CSL Main Business

Table 123. CSL Latest Developments

Table 124. MedImmune LLC Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 125. MedImmune LLC Vaccines For Children (VFC) Product Offered

Table 126. MedImmune LLC Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 127. MedImmune LLC Main Business

Table 128. MedImmune LLC Latest Developments

Table 129. J&J(Crucell) Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 130. J&J(Crucell) Vaccines For Children (VFC) Product Offered

Table 131. J&J(Crucell) Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 132. J&J(Crucell) Main Business

Table 133. J&J(Crucell) Latest Developments

Table 134. China National Biotec Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 135. China National Biotec Vaccines For Children (VFC) Product Offered

Table 136. China National Biotec Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 137. China National Biotec Main Business

Table 138. China National Biotec Latest Developments

Table 139. Tiantan Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 140. Tiantan Vaccines For Children (VFC) Product Offered

Table 141. Tiantan Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 142. Tiantan Main Business

Table 143. Tiantan Latest Developments

Table 144. Hualan Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 145. Hualan Vaccines For Children (VFC) Product Offered

Table 146. Hualan Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 147. Hualan Main Business

Table 148. Hualan Latest Developments

Table 149. Kangtai Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 150. Kangtai Vaccines For Children (VFC) Product Offered

Table 151. Kangtai Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 152. Kangtai Main Business

Table 153. Kangtai Latest Developments

Table 154. Hissen Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors

Table 155. Hissen Vaccines For Children (VFC) Product Offered

Table 156. Hissen Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 157. Hissen Main Business

Table 158. Hissen Latest Developments

List of Figures

Figure 1. Picture of Vaccines For Children (VFC)

Figure 2. Vaccines For Children (VFC) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vaccines For Children (VFC) Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Vaccines For Children (VFC) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Vaccines For Children (VFC) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Recombinant Vaccines

Figure 10. Product Picture of Viral Vaccines

Figure 11. Product Picture of Polysaccharide Vaccines

Figure 12. Product Picture of Others

Figure 13. Global Vaccines For Children (VFC) Sales Market Share by Type in 2021

Figure 14. Global Vaccines For Children (VFC) Revenue Market Share by Type (2017-2022)

Figure 15. Vaccines For Children (VFC) Consumed in Government Institution

Figure 16. Global Vaccines For Children (VFC) Market: Government Institution (2017-2022) & (K Doses)

Figure 17. Vaccines For Children (VFC) Consumed in Private Sector

Figure 18. Global Vaccines For Children (VFC) Market: Private Sector (2017-2022) & (K Doses)

Figure 19. Vaccines For Children (VFC) Consumed in Other

Figure 20. Global Vaccines For Children (VFC) Market: Other (2017-2022) & (K Doses)

Figure 21. Global Vaccines For Children (VFC) Sales Market Share by Application (2017-2022)

Figure 22. Global Vaccines For Children (VFC) Revenue Market Share by Application in 2021

Figure 23. Vaccines For Children (VFC) Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Vaccines For Children (VFC) Revenue Market Share by Company in 2021

Figure 25. Global Vaccines For Children (VFC) Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Vaccines For Children (VFC) Revenue Market Share by Geographic Region in 2021

Figure 27. Global Vaccines For Children (VFC) Sales Market Share by Region (2017-2022)

Figure 28. Global Vaccines For Children (VFC) Revenue Market Share by Country/Region in 2021

Figure 29. Americas Vaccines For Children (VFC) Sales 2017-2022 (K Doses)

Figure 30. Americas Vaccines For Children (VFC) Revenue 2017-2022 ($ Millions)

Figure 31. APAC Vaccines For Children (VFC) Sales 2017-2022 (K Doses)

Figure 32. APAC Vaccines For Children (VFC) Revenue 2017-2022 ($ Millions)

Figure 33. Europe Vaccines For Children (VFC) Sales 2017-2022 (K Doses)

Figure 34. Europe Vaccines For Children (VFC) Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Vaccines For Children (VFC) Sales 2017-2022 (K Doses)

Figure 36. Middle East & Africa Vaccines For Children (VFC) Revenue 2017-2022 ($ Millions)

Figure 37. Americas Vaccines For Children (VFC) Sales Market Share by Country in 2021

Figure 38. Americas Vaccines For Children (VFC) Revenue Market Share by Country in 2021

Figure 39. United States Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Vaccines For Children (VFC) Sales Market Share by Region in 2021

Figure 44. APAC Vaccines For Children (VFC) Revenue Market Share by Regions in 2021

Figure 45. China Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Vaccines For Children (VFC) Sales Market Share by Country in 2021

Figure 52. Europe Vaccines For Children (VFC) Revenue Market Share by Country in 2021

Figure 53. Germany Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Vaccines For Children (VFC) Revenue Market Share by Country in 2021

Figure 60. Egypt Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Vaccines For Children (VFC) Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Vaccines For Children (VFC) in 2021

Figure 66. Manufacturing Process Analysis of Vaccines For Children (VFC)

Figure 67. Industry Chain Structure of Vaccines For Children (VFC)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles